RDF/XML JSON-LD N3/Turtle RDF/JSON

Melguizo Alonso, Consolación Author

DNA methylation patterns as molecular biomarkers: An overview in colorectal cancer

  • González-Flores E.
  • Hernández R.
  • Álvarez P.
  • Cabeza L.
  • Perazzoli G.
  • Zafra I.
  • Melguizo C.
  • Prados J.
  • Rama A.
... View more Collapse

European Journal of Anatomy - 1/7/2018

Cite count: 1 (Web of Science)
  • SJR Quartile: Q3
  • CiteScore: 0.5 (2020)
  • SJR: 0.174 (2018
  • SNIP: 0.289 (2018
  • SJR Categories: Anatomy (Q3)

Latest in Vitro and in Vivo Assay, Clinical Trials and Patents in Cancer Treatment using Curcumin: A Literature Review

  • Doello K.
  • Ortiz R.
  • Alvarez P.
  • Melguizo C.
  • Cabeza L.
  • Prados J.

NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL - 19/5/2018

10.1080/01635581.2018.1464347

Cite count: 40 (Web of Science) 26 (Scopus)
  • SJR Quartile: Q2
  • JCR Impact Factor: 2.029 (2018)
  • CiteScore: 4.1 (2020)
  • SJR: 0.736 (2018
  • SNIP: 0.672 (2018
  • JCR 5-year Impact Factor: 2.456
  • JCR Categories: NUTRITION & DIETETICS
  • SJR Categories: Medicine (miscellaneous) (Q2); Nutrition and Dietetics (Q2); Cancer Research (Q3); Oncology (Q3)

Formulation and in vitro evaluation of magnetoliposomes as a potential nanotool in colorectal cancer therapy

  • Lorente C.
  • Cabeza L.
  • Clares B.
  • Ortiz R.
  • Halbaut L.
  • Delgado Á.
  • Perazzoli G.
  • Prados J.
  • Arias J.
  • Melguizo C.
... View more Collapse

COLLOIDS AND SURFACES B-BIOINTERFACES - 1/11/2018

10.1016/j.colsurfb.2018.07.070

Cite count: 20 (Web of Science) 13 (Scopus)
  • SJR Quartile: Q1
  • JCR Impact Factor: 3.973 (2018)
  • CiteScore: 8.2 (2020)
  • SJR: 0.957 (2018
  • SNIP: 1.065 (2018
  • JCR 5-year Impact Factor: 4.18
  • JCR Categories: MATERIALS SCIENCE, BIOMATERIALS
  • SJR Categories: Medicine (miscellaneous) (Q1); Surfaces and Interfaces (Q1); Biotechnology (Q2); Colloid and Surface Chemistry (Q2); Physical and Theoretical Chemistry (Q2)

Nanoemulsion strategy for ursolic and oleanic acids isolates from plumeria obtusa improves antioxidant and cytotoxic activity in melanoma cells

  • Alvarado H.L.
  • Calpena A.C.
  • Garduño-Ramírez M.L.
  • Ortiz R.
  • Melguizo C.
  • Prados J.C.
  • Clares B.
... View more Collapse

Anti-Cancer Agents in Medicinal Chemistry - 1/1/2018

10.2174/1871520618666180111151846

Cite count: 7 (Web of Science) 9 (Scopus)
  • SJR Quartile: Q3
  • JCR Impact Factor: 2.18 (2018)
  • CiteScore: 3.5 (2020)
  • SJR: 0.528 (2018
  • SNIP: 0.687 (2018
  • JCR 5-year Impact Factor: 2.418
  • JCR Categories: CHEMISTRY, MEDICINAL
  • SJR Categories: Cancer Research (Q3); Molecular Medicine (Q3); Pharmacology (Q3)

Proteomic biomarkers in body fluids associated with pancreatic cancer

  • Jimenez-Luna C.
  • Torres C.
  • Ortiz R.
  • Dieguez C.
  • Martinez-Galan J.
  • Melguizo C.
  • Prados J.
  • Caba O.
... View more Collapse

Oncotarget - 1/1/2018

10.18632/oncotarget.24654

Cite count: 21 (Scopus)
  • SJR Quartile: Q1
  • SJR Categories: Oncology (Q1)

Nano-engineering of biomedical prednisolone liposomes: evaluation of the cytotoxic effect on human colon carcinoma cell lines

  • Lorente C.
  • Arias J.
  • Cabeza L.
  • Ortiz R.
  • Prados J.
  • Melguizo C.
  • Delgado Á.
  • Clares-Naveros B.
... View more Collapse

Journal of Pharmacy and Pharmacology - 1/04/2018

10.1111/jphp.12882

Cite count: 4 (Web of Science) 4 (Scopus)
  • SJR Quartile: Q2
  • JCR Impact Factor: 2.39 (2018)
  • CiteScore: 5 (2020)
  • SJR: 0.568 (2018
  • SNIP: 0.79 (2018
  • JCR 5-year Impact Factor: 2.728
  • JCR Categories: PHARMACOLOGY & PHARMACY
  • SJR Categories: Pharmaceutical Science (Q2); Pharmacology (Q3)
Open Access

Development of biomedical 5-fluorouracil nanoplatforms for colon cancer chemotherapy: Influence of process and formulation parameters

  • Pretel E.
  • Arias J.
  • Cabeza L.
  • Melguizo C.
  • Prados J.
  • Mallandrich M.
  • Suñer J.
  • Clares B.
... View more Collapse

INTERNATIONAL JOURNAL OF PHARMACEUTICS - 15/9/2017

10.1016/j.ijpharm.2017.07.055

Cite count: 15 (Web of Science) 9 (Scopus)
  • SJR Quartile: Q1
  • JCR Impact Factor: 3.862 (2017)
  • CiteScore: 8.6 (2020)
  • SJR: 1.172 (2017
  • SNIP: 1.302 (2017
  • JCR 5-year Impact Factor: 4.229
  • JCR Categories: PHARMACOLOGY & PHARMACY
  • SJR Categories: Pharmaceutical Science (Q1)
Open Access

Improved antitumor activity and reduced toxicity of doxorubicin encapsulated in poly(?-caprolactone) nanoparticles in lung and breast cancer treatment: An in vitro and in vivo study

  • Cabeza L.
  • Ortiz R.
  • Prados J.
  • Delgado Á.
  • Martín-Villena M.
  • Clares B.
  • Perazzoli G.
  • Entrena J.
  • Melguizo C.
  • Arias J.
... View more Collapse

EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES - 1/5/2017

10.1016/j.ejps.2017.02.026

Cite count: 46 (Web of Science) 33 (Scopus)
  • SJR Quartile: Q1
  • JCR Impact Factor: 3.466 (2017)
  • CiteScore: 7.8 (2020)
  • SJR: 1.016 (2017
  • SNIP: 1.319 (2017
  • JCR 5-year Impact Factor: 3.869
  • JCR Categories: PHARMACOLOGY & PHARMACY
  • SJR Categories: Pharmaceutical Science (Q1)
Open Access

Untargeted LC-HRMS-based metabolomics for searching new biomarkers of pancreatic ductal adenocarcinoma: A pilot study

  • Peces S.R.
  • Navarro C.D.
  • López C.M.
  • Caba O.
  • Jiménez-Luna C.
  • Melguizo C.
  • Prados J.C.
  • Genilloud O.
  • Pérez F.V.
  • Del Palacio J.P.
... View more Collapse

SLAS Discovery - 1/4/2017

10.1177/1087057116671490

Cite count: 12 (Web of Science) 9 (Scopus)
  • CiteScore: 5.1 (2020)
  • JCR Categories: BIOTECHNOLOGY & APPLIED MICROBIOLOGY
  • SJR Categories: Analytical Chemistry; Biochemistry; Biotechnology; Molecular Medicine
Open Access

Tripalmitin nanoparticle formulations significantly enhance paclitaxel antitumor activity against breast and lung cancer cells in vitro

  • Leiva M.
  • Ortiz R.
  • Contreras-Cáceres R.
  • Perazzoli G.
  • Mayevych I.
  • López-Romero J.
  • Sarabia F.
  • Baeyens J.
  • Melguizo C.
  • Prados J.
... View more Collapse

Scientific Reports - 1/12/2017

10.1038/s41598-017-13816-z

Cite count: 26 (Web of Science) 16 (Scopus)
  • SJR Quartile: Q1
  • JCR Impact Factor: 4.122 (2017)
  • CiteScore: 7.1 (2020)
  • SJR: 1.533 (2017
  • SNIP: 1.263 (2017
  • JCR 5-year Impact Factor: 4.609
  • JCR Categories: MULTIDISCIPLINARY SCIENCES
  • SJR Categories: Multidisciplinary (Q1)

Role of cancer stem cells of breast, colon, and melanoma tumors in the response to antitumor therapy

  • Marchal J.
  • García M.
  • Boulaiz H.
  • Perán M.
  • Álvarez P.
  • Prados J.
  • Melguizo C.
  • Aránega A.
... View more Collapse

Stem Cells and Cancer Stem Cells, Volume 3: Stem Cells and Cancer Stem Cells, Therapeutic Applications in Disease and Injury: Volume 3 - 1/1/2012

10.1007/978-94-007-2415-0_15

Cite count:

The story of a doctoral thesis: GEF, a new gene with applications in anti-tumor gene therapy

  • Boulaiz, H
  • Prados, J
  • Melguizo, C
  • Marchal, JA
  • Carrillo, E
  • Velez, C
  • Fernandez, JE
  • Alvarez, L
  • Caba, O
  • Aranega, A
... View more Collapse

CELLULAR AND MOLECULAR BIOLOGY - 06/2003

  • JCR Quartile: Q4 (2003)
  • SJR Quartile: Q1
  • JCR Impact Factor: 1.153 (2022)
  • SJR Categories: Medicine (miscellaneous) (Q1)

This author has no conferences.

This author has no patents.

Nanomedicine and Hyperthermia for the Treatment of Gastrointestinal Cancer: A Systematic Review

  • Lidia Gago
  • Francisco Quiñonero
  • Gloria Perazzoli
  • Consolacion Melguizo
  • Jose Prados
  • Raul Ortiz
  • Laura Cabeza
... View more Collapse

Pharmaceutics - 13/06/2023

10.3390/pharmaceutics15071958

Cite count: 2 (Web of Science) 1 (Scopus)
Open Access

Synthesis, solubility and antitumor activity of maslinic acid derivatives

  • Fuentes-Rios, D.
  • Cepero, A.
  • Garcia-Castro, M.
  • Contreras-Caceres, R.
  • Lopez-Romero, J. M.
  • Luque, C.
  • Cabeza, L.
  • Melguizo, C.
  • Prados, J.
... View more Collapse

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY REPORTS - 4/2022

10.1016/j.ejmcr.2022.100032

Cite count: 4 (Web of Science)

Correction: Specific driving of the suicide E gene by the CEA promoter enhances the effects of paclitaxel in lung cancer (Cancer Gene Therapy, (2019), 10.1038/s41417-019-0137-3)

  • Ballesteros A.
  • Hernández R.
  • Perazzoli G.
  • Cabeza L.
  • Melguizo C.
  • Vélez C.
  • Prados J.
... View more Collapse

CANCER GENE THERAPY - 1/1/2020

10.1038/s41417-020-0166-y

Cite count:
  • JCR Impact Factor: 5.987 (2020)
  • CiteScore: 8.1 (2020)
  • SJR: 1.535 (2020
  • SNIP: 1.113 (2020
  • JCR 5-year Impact Factor: 5.358
  • JCR Categories: MEDICINE, RESEARCH & EXPERIMENTAL
Open Access

Downregulated microRNAs in the colorectal cancer: Diagnostic and therapeutic perspectives

  • Hernández R.
  • Sánchez-Jiménez E.
  • Melguizo C.
  • Prados J.
  • Rama A.R.

BMB Reports - 1/1/2018

10.5483/bmbrep.2018.51.11.116

Cite count: 19 (Web of Science) 12 (Scopus)
  • SJR Quartile: Q1
  • JCR Impact Factor: 2.966 (2018)
  • CiteScore: 6 (2020)
  • SJR: 1.082 (2018
  • SNIP: 0.952 (2018
  • JCR 5-year Impact Factor: 2.838
  • JCR Categories: BIOCHEMISTRY & MOLECULAR BIOLOGY
  • SJR Categories: Medicine (miscellaneous) (Q1); Biochemistry (Q2); Molecular Biology (Q2)

Scopus: 27

Web of Science: 30

Scopus: 78

Web of Science: 90

Last data update: 6/1/24 7:44 AM
Next scheduled update: 6/8/24 3:00 AM